Development and Validation of a Duplex ddPCR Assay for CMV and EBV Detection

Zhaoxiang Du's research article describes the development and validation of a duplex droplet digital PCR assay for simultaneous detection of cytomegalovirus and Epstein-Barr virus in plasma. The study, published on figshare in March 2026, includes performance metrics against qPCR and clinical validation results from 117 plasma samples.

Use Cases

• Benchmarking ddPCR assay performance based on described sensitivity and specificity metrics
• Evaluating detection methods for viral coinfection based on the assay's simultaneous quantification capability
• Assessing tolerance to interfering substances in clinical samples based on the hyperlipidemia/hyperbilirubinemia tests

Strengths

• Clinical validation performed on 117 plasma samples
• Assay demonstrated 100% sensitivity and specificity compared to a reference kit
• Limit of detection for CMV and EBV reported as 7.9 and 6.5 copies/reaction

Limitations

• Dataset consists of a single 26.1 MB DOCX file; actual data tables or raw measurements are not directly accessible
• Column-level documentation is absent; field semantics must be inferred after download
• Row count is unknown, which may limit suitability assessment

Provenance

Source

Zhaoxiang Du

Collection Method

Research study involving assay optimization and clinical validation using plasma samples.

Freshness

Last updated 2026-03-19 06:27:21